港股异动 | 金斯瑞生物科技(01548)涨超5%再创新高 近期与礼来达成合作 AIDD驱动生命科学强劲增长

智通财经
Oct 06

智通财经APP获悉,金斯瑞生物科技(01548)早盘涨超5%,高见48.38港元,再度刷新历史新高。截至发稿,涨5.74%,报48.26港元,成交额9562.46万港元。

消息面上,金斯瑞近期宣布与礼来的AIDD协作平台Lilly TuneLab达成合作。根据协议,公司将向TuneLab参与企业提供湿实验服务,助力其快速生成实验数据,将AI预测转化为生物学验证数据,加速候选药物评估。摩根大通表示,此举是进入100多家Biotech客户生态、打通干湿实验闭环的战略入口

中信建投则指出,金斯瑞上半年AIDD相关收入接近4000万美元,并预计未来几年有望保持快速增长,近期完成港股配售,募集资金预计主要用于AIDD产能建设,随着AI制药从计算科学逐步走向与实验科学的深度融合,公司有望持续受益。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10